{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:49:40Z","timestamp":1791442180491,"version":"4.3.3"},"reference-count":29,"publisher":"BMJ","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Guangdong Provincial Clinical Research Center for Neurological Diseases","award":["2020B1111170002"],"award-info":[{"award-number":["2020B1111170002"]}]},{"name":"Guangzhou Science and Technology Program Key Projects","award":["202007030010"],"award-info":[{"award-number":["202007030010"]}]},{"name":"Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases","award":["2020B1212060017"],"award-info":[{"award-number":["2020B1212060017"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Stroke Vasc Neurol"],"accepted":{"date-parts":[[2026,8,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Evidence regarding tenecteplase (TNK) use at primary stroke centres (PSCs) remains limited. PSCs often serve as the initial or sole point of care for acute ischaemic stroke (AIS) patients. We aimed to assess the effectiveness and safety of TNK at PSCs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Consecutive AIS patients receiving TNK or alteplase within 4.5\u2009hours at PSCs in China from 1 January to 31 December 2023 were included retrospectively. Propensity score matching (PSM) was used to match TNK-treated and alteplase-treated patients 1:1 and their effectiveness and safety were compared. The primary effectiveness outcome was modified Rankin Scale (mRS) 0\u20131 at 90 days, while the key safety outcome was post-thrombolysis symptomatic intracranial haemorrhage (sICH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 4000 cases from 62 PSCs (TNK: 1670; alteplase: 2330). After PSM, 1552 cases per group were analysed. There was no significant difference between the two groups in the proportion of patients achieving mRS 0\u20131 at 90 days (69.7% vs 70.9%, p=0.472). No differences in functional outcome or sICH were observed in adjusted analyses. Exploratory subgroup analyses suggested a potential association between TNK and improved outcomes in patients with large artery atherosclerosis (LAA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TNK showed comparable effectiveness and safety to alteplase for AIS patients at PSCs. Exploratory subgroup findings in LAA require confirmation in future prospective studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/svn-2025-004998","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:55:15Z","timestamp":1791438915000},"page":"svn-2025-004998","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness and safety of tenecteplase for acute ischaemic stroke at primary stroke centres: a multicentre retrospective study"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2747-6274","authenticated-orcid":false,"given":"Jingjing","family":"Li","sequence":"first","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University; Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases; National Key Clinical Department and Key Discipline of Neurology, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9380-2605","authenticated-orcid":false,"given":"Yuhua","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University; Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases; National Key Clinical Department and Key Discipline of Neurology, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Public Health and Management, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University; Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases; National Key Clinical Department and Key Discipline of Neurology, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Dang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University; Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases; National Key Clinical Department and Key Discipline of Neurology, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2687-0640","authenticated-orcid":false,"given":"Shihui","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University; Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases; National Key Clinical Department and Key Discipline of Neurology, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4280-0439","authenticated-orcid":false,"given":"Jinsheng","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University; Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases; National Key Clinical Department and Key Discipline of Neurology, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"2026100722550883000_svn-2025-004998v1.1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/23969873221150022","article-title":"European Stroke Organisation (ESO) expedited recommendation on tenecteplase for acute ischaemic stroke","volume":"8","author":"Alamowitch","year":"2023","journal-title":"Eur Stroke J"},{"key":"2026100722550883000_svn-2025-004998v1.2","unstructured":"Intercollegiate Stroke Working Party . National clinical guideline for stroke for the UK and Ireland. London, 2023."},{"key":"2026100722550883000_svn-2025-004998v1.3","unstructured":"Chinese Society of Neurology, Chinese Stroke Society . Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2023. Chin J Neurol 2023;57."},{"key":"2026100722550883000_svn-2025-004998v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02600-9"},{"key":"2026100722550883000_svn-2025-004998v1.5","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2021-000978"},{"key":"2026100722550883000_svn-2025-004998v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01054-6"},{"key":"2026100722550883000_svn-2025-004998v1.7","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamaneurol.2023.1449","article-title":"Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke: The Comparative Effectiveness of Routine Tenecteplase vs Alteplase in Acute Ischemic Stroke (CERTAIN) Collaboration","volume":"80","author":"Warach","year":"2023","journal-title":"JAMA Neurol"},{"key":"2026100722550883000_svn-2025-004998v1.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716405"},{"key":"2026100722550883000_svn-2025-004998v1.9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.14721"},{"key":"2026100722550883000_svn-2025-004998v1.10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.0548","article-title":"Short-Term Safety and Effectiveness for Tenecteplase and Alteplase in Acute Ischemic Stroke","volume":"8","author":"Rousseau","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026100722550883000_svn-2025-004998v1.11","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2024-003381"},{"key":"2026100722550883000_svn-2025-004998v1.12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12975-019-00727-6","article-title":"Stroke Center Care and Outcome: Results from the CSPPC Stroke Program","volume":"11","author":"Shen","year":"2020","journal-title":"Transl Stroke Res"},{"key":"2026100722550883000_svn-2025-004998v1.13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/17474930241286709","article-title":"Clinical characteristics, in-hospital management, and outcomes among patients hospitalized for acute ischemic stroke in rural versus urban hospitals in China: A nationwide hospital-based study","volume":"20","author":"Zhu","year":"2025","journal-title":"Int J Stroke"},{"key":"2026100722550883000_svn-2025-004998v1.14","first-page":"783","article-title":"Brief report on stroke prevention and treatment in China, 2021","volume":"20","year":"2023","journal-title":"Chin J Cerebrovasc Dis"},{"key":"2026100722550883000_svn-2025-004998v1.15","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.24.1.35"},{"key":"2026100722550883000_svn-2025-004998v1.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804656"},{"key":"2026100722550883000_svn-2025-004998v1.17","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.19.5.604"},{"key":"2026100722550883000_svn-2025-004998v1.18","article-title":"Comparison between healthcare quality in primary stroke centers and comprehensive stroke centers for acute stroke patients: evidence from the Chinese Stroke Center Alliance","volume":"38","author":"Liu","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"2026100722550883000_svn-2025-004998v1.19","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2018-014206"},{"key":"2026100722550883000_svn-2025-004998v1.20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/1747493017701151","article-title":"Thrombectomy accessibility after transfer from a primary stroke center: Analysis of a three-year prospective registry","volume":"12","author":"Sablot","year":"2017","journal-title":"Int J Stroke"},{"key":"2026100722550883000_svn-2025-004998v1.21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/23969873231206894","article-title":"Intravenous thrombolysis with tenecteplase versus alteplase combined with endovascular treatment of anterior circulation tandem occlusions: A pooled analysis of ETIS and TETRIS","volume":"9","author":"Marnat","year":"2024","journal-title":"Eur Stroke J"},{"key":"2026100722550883000_svn-2025-004998v1.22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/23969873221113729","article-title":"Treatment times, functional outcome, and hemorrhage rates after switching to tenecteplase for stroke thrombolysis: Insights from the TETRIS registry","volume":"7","author":"Gerschenfeld","year":"2022","journal-title":"Eur Stroke J"},{"key":"2026100722550883000_svn-2025-004998v1.23","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.035931"},{"key":"2026100722550883000_svn-2025-004998v1.24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.5853\/jos.2024.01284","article-title":"Ethnic Differences in the Safety and Efficacy of Tenecteplase Versus Alteplase for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis","volume":"26","author":"Koh","year":"2024","journal-title":"J Stroke"},{"key":"2026100722550883000_svn-2025-004998v1.25","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12243-1"},{"key":"2026100722550883000_svn-2025-004998v1.26","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.122.038950"},{"key":"2026100722550883000_svn-2025-004998v1.27","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.030859"},{"key":"2026100722550883000_svn-2025-004998v1.28","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.031692","article-title":"Comprehensive Review of Tenecteplase for Thrombolysis in Acute Ischemic Stroke","volume":"13","author":"Wang","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2026100722550883000_svn-2025-004998v1.29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jocn.2024.06.005","article-title":"Number needed to treat with intravenous tenecteplase to reduce the need for mechanical thrombectomy in large vessel occlusion acute ischemic stroke patients: A retrospective look at real-world experience data","volume":"126","author":"Platko","year":"2024","journal-title":"J Clin Neurosci"}],"container-title":["Stroke and Vascular Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/svn-2025-004998","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:55:19Z","timestamp":1791438919000},"score":1,"resource":{"primary":{"URL":"https:\/\/svn.bmj.com\/lookup\/doi\/10.1136\/svn-2025-004998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":29,"alternative-id":["10.1136\/svn-2025-004998"],"URL":"https:\/\/doi.org\/10.1136\/svn-2025-004998","relation":{},"ISSN":["2059-8688","2059-8696"],"issn-type":[{"value":"2059-8688","type":"print"},{"value":"2059-8696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]}}}